APA (7th ed.) Citation

H, M., G, B., G, F., C, C., C, B., R, O., . . . M, A. (2022). Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cellular and molecular life sciences : CMLS, 79(8), 465. https://doi.org/10.1007/s00018-022-04487-9

Chicago Style (17th ed.) Citation

H, Mameri, Buhagiar-Labarchède G, Fontaine G, Corcelle C, Barette C, Onclercq-Delic R, Beauvineau C, Mahuteau-Betzer F, and Amor-Guéret M. "Cytidine Deaminase Deficiency in Tumor Cells Is Associated with Sensitivity to a Naphthol Derivative and a Decrease in Oncometabolite Levels." Cellular and Molecular Life Sciences : CMLS 79, no. 8 (2022): 465. https://doi.org/10.1007/s00018-022-04487-9.

MLA (9th ed.) Citation

H, Mameri, et al. "Cytidine Deaminase Deficiency in Tumor Cells Is Associated with Sensitivity to a Naphthol Derivative and a Decrease in Oncometabolite Levels." Cellular and Molecular Life Sciences : CMLS, vol. 79, no. 8, 2022, p. 465, https://doi.org/10.1007/s00018-022-04487-9.